Camarda Financial Advisors, LLC Innoviva, Inc. Transaction History

Camarda Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	SELL	$13.63 - $15.7 $1.1 Million - $1.27 Million	-80,609 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$13.44 - $17.59 $103,958 - $136,058	-7,735 Reduced 8.76%	80,609 $1.11 Million
Q1 2018 Apr 30, 2018	SELL	$13.8 - $16.99 $205,261 - $252,709	-14,874 Reduced 14.41%	88,344 $1.47 Million
Q4 2017 Feb 07, 2018	SELL	$11.73 - $14.75 $124,079 - $156,025	-10,578 Reduced 9.3%	103,218 $1.47 Million
Q3 2017 Nov 15, 2017	BUY	$12.06 - $14.12 $1.37 Million - $1.61 Million	113,796	113,796 $1.61 Million

222

79.7M

20K

5.4K

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.36B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.